All Insights Report Future Of Pharma: Evolving Commercial Models - Part 2

    Future Of Pharma: Evolving Commercial Models - Part 2

    Commercial Models

    Future Of Pharma: Evolving Commercial Models - Part 2

    Actionable recommendations to address go-to-market complexities.

    Future Of Pharma: Evolving Commercial Models - Part 2

    In the first part of this two-part series, we presented our findings from the Future of Pharma survey. In this second report, we will share actionable recommendations on what can be done to address the gaps identified.

    As Pharma companies seek to create a better patient experience at every step of their healthcare journey, commercial organizations must transform to deal with the go-to-market complexity seamlessly. The commercial leaders who are prudent, invest ahead of time and pay keen attention to the oncoming business transformation through technology, processes, and change management of the organization and people will be the ones who emerge as leaders.

    Learn what several senior pharma commercial operations leaders think of the potential implications of industry challenges on business operations, sales, and marketing objectives and how the commercial models will evolve in the future.

    Contact us at connect@axtria.com with any questions.

    Complete the brief form to download the white paper

    Recommended insights

    Evolving Commercial Models Report Part 2

    White Paper

    The Evolution and Future of Integrated Evidence Planning

    Evolving Commercial Models Report Part 2

    Case Study

    Driving $25 Million Impact with a Data Science and Analytics Center of Excellence

    Evolving Commercial Models Report Part 2

    Report

    Predictive Horizons: Unveiling Cardiovascular Insights with Conditional Inference Trees